H-1B sponsorship profile: Solaris Pharma. Across U.S. Department of Labor LCA disclosures, Solaris Pharma filed 9 Labor Condition Applications covering 9 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (9 certified of 9 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Solaris Pharma’s H-1B petitions range from $50,880 at the low end to $162,000 at the high end, with a petition-weighted average of $99,112. That range reflects the mix of occupations the company sponsors, led by Sr. Manager Regulatory (2 petitions at $162,000 avg), followed by Research Associate and Analytical Research Scientist. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Solaris Pharma is headquartered in Bridgewater, NJ , NJ under NAICS code 541714, and places H-1B workers across 1 state, most heavily in NJ. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Solaris Pharma ranks. By H-1B petition volume, Solaris Pharma is #17,879 of 119,880 employers nationally and #1,461 of 5,818 employers headquartered in NJ. Both ranks are computed live from the same underlying petition counts, not a separate estimate.